EU clears Roche's flu drug Xofluza in very young children

With this year's influenza season off to an early start and showing signs of being particularly aggressive, the EU has extended the approved uses of Roche's antiviral Xofluza to include tre

FDA approves Roche's Xofluza to prevent flu spreading in fam...

The FDA has approved a new use for Xofluza (baloxavir marboxil) from Roche’s Genentech unit, to prevent people developing flu after coming into contact with an infectious person.

Roche’s Herceptin/Perjeta combo product nears EU approval

The EMA’s human medicines committee has recommended approval of a fixed-dose combination of Roche’s breast cancer drugs Herceptin and Perjeta – part of the company’s defense against Hercept

Roche’s Xofluza limits spread of flu virus, says new study

Sanofi licenses OTC Tamiflu rights for the US market